These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6342542)

  • 1. Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial.
    Rudd P; Montanez P; Hallidie-Smith K; Silverman M
    Arch Dis Child; 1983 Apr; 58(4):267-70. PubMed ID: 6342542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin for closure of patent ductus arteriosus in prematures.
    Mullett MD; Croghan TW; Myerberg DZ; Krall JM; Neal WA
    Clin Pediatr (Phila); 1982 Apr; 21(4):217-20. PubMed ID: 7039927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus.
    Hammerman C; Aramburo MJ
    J Pediatr; 1990 Nov; 117(5):771-6. PubMed ID: 2231212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants.
    Mahony L; Carnero V; Brett C; Heymann MA; Clyman RI
    N Engl J Med; 1982 Mar; 306(9):506-10. PubMed ID: 7035955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind study of the effects of oral indomethacin in preterm infants with patent ductus arteriosus who failed medical management.
    Neu J; Ariagno RL; Johnson JD; Pitlick PT; Cohen RS; Beets CL; Sunshine P
    Pediatr Pharmacol (New York); 1981; 1(3):245-9. PubMed ID: 7346744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.
    Supapannachart S; Khowsathit P; Patchakapati B
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S87-92. PubMed ID: 10730525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin for the prevention of symptomatic patent ductus arteriosus in very low birth weight infants.
    Lai TH; Soong WJ; Hwang B
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1990; 31(1):17-23. PubMed ID: 2278224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of prophylactic indomethacin to improve the outcome of the very low birth weight infant.
    Hammerman C; Strates E; Komar K; Bui K
    Dev Pharmacol Ther; 1987; 10(6):393-404. PubMed ID: 3677969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus--a double-blind controlled study.
    Yeh TF; Luken JA; Thalji A; Raval D; Carr I; Pildes RS
    J Pediatr; 1981 Jan; 98(1):137-45. PubMed ID: 7005415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial.
    Merritt TA; Harris JP; Roghmann K; Wood B; Campanella V; Alexson C; Manning J; Shapiro DL
    J Pediatr; 1981 Aug; 99(2):281-6. PubMed ID: 7019406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin therapy on the first day of life in infants with very low birth weight.
    Mahony L; Caldwell RL; Girod DA; Hurwitz RA; Jansen RD; Lemons JA; Schreiner RL
    J Pediatr; 1985 May; 106(5):801-5. PubMed ID: 3998921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus.
    Kluckow M; Jeffery M; Gill A; Evans N
    Arch Dis Child Fetal Neonatal Ed; 2014 Mar; 99(2):F99-F104. PubMed ID: 24317704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive management of hypoglycemia in very low-birthweight infants following indomethacin therapy for patent ductus arteriosus.
    Hosono S; Ohono T; Kimoto H; Nagoshi R; Shimizu M; Nozawa M
    Pediatr Int; 2001 Oct; 43(5):465-8. PubMed ID: 11737706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic management of patent ductus arteriosus.
    Bhatt V; Nahata MC
    Clin Pharm; 1989 Jan; 8(1):17-33. PubMed ID: 2643499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor response to oral indomethacin therapy for persistent ductus arteriosus in very low birthweight infants.
    Cooke RW; Pickering D
    Br Heart J; 1979 Mar; 41(3):301-3. PubMed ID: 426980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of indomethacin and its relationship to retinopathy of prematurity in very low birthweight infants.
    Procianoy RS; Garcia-Prats JA; Hittner HM; Adams JM; Rudolph AJ
    Arch Dis Child; 1980 May; 55(5):362-4. PubMed ID: 7436472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.